Literature DB >> 11076104

Effect of hemodialysis on protein synthesis.

E Löfberg1, P Essén, M McNurlan, J Wernerman, P Garlick, B Anderstam, J Bergström, A Alvestrand.   

Abstract

BACKGROUND: Earlier studies have shown that hemodialysis (HD) treatment stimulates net protein catabolism. Several factors associated with HD affect protein catabolism, such as an inflammatory effect due to blood-membrane contact and loss of amino acids and glucose into the dialysate. SUBJECTS,
MATERIAL AND METHODS: We have studied protein synthesis in skeletal muscle of healthy volunteers (n = 9) before and after a single heparin-free HD. Protein synthesis (PS) was studied, using 2 independent techniques: the incorporation of labeled 2H5-phenylalanine into muscle protein, which gives a quantitative measure of the fractional synthesis rate of muscle proteins, and the concentration and size distribution of ribosomes, which gives a qualitative estimate of protein synthesis. Furthermore, free amino acid concentrations were determined in muscle and plasma.
RESULTS: The rate of PS, expressed as the fractional synthesis rate, decreased by 13% during HD (p < 0.02). The capacity for PS, as reflected by the total concentration of ribosomes, was reduced by 22% (p < 0.02) and the activity of PS, expressed as the relative proportion of polyribosomes, decreased from 48.4 +/- 0.9% to 44.8 +/- 0.8% after dialysis (p < 0.01). There was a total loss of 5.8 +/- 0.3 g amino acid to the dialysate. Plasma and muscle free amino acid concentrations were determined at four time points; before and after the phenylalanine incorporation period, before dialysis and before and after the second incorporation period after dialysis. Immediately after dialysis, there was a decrease in plasma asparagine, histidine, alanine, taurine, valine and tryptophane. In muscle, no changes occurred except for a slight increase in leucine after dialysis. In blood, the glucose concentration decreased and the total amount of glucose lost to the dialysate was 21 +/- 3.0 g. In summary, one single hemodialysis treatment decreases fractional protein synthesis rate in skeletal muscle.
CONCLUSION: The results demonstrate substantial losses of amino acids and glucose to the dialysate and decreased amino acid concentrations in plasma, but only minimal changes in the intracellular amino acid concentrations in muscle, suggesting that the decreased PS is caused not by lack of amino acid precursors at the site of the synthesis activity, but by other mechanisms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11076104

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  4 in total

Review 1.  Critical appraisal of biomarkers of dietary intake and nutritional status in patients undergoing dialysis.

Authors:  Juan Jesús Carrero; Joline Chen; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Semin Dial       Date:  2014-07-10       Impact factor: 3.455

2.  Glutamine kinetics during intravenous glutamine supplementation in ICU patients on continuous renal replacement therapy.

Authors:  A Berg; A Norberg; C-R Martling; L Gamrin; O Rooyackers; J Wernerman
Journal:  Intensive Care Med       Date:  2007-02-22       Impact factor: 17.440

3.  Continuous intradialytic amino acid infusion from the start of dialysis is better to avoid catabolism under the high-volume pre-dilution on-line HDF.

Authors:  Motoko Kato; Shunichiro Urabe; Shohei Matsuzawa; Akira Kato; Momoko Fukazawa; Emi Hiyama; Asami Kurii; Noriko Mikami; Yukie Kitajima; Miho Hida; Kenichi Kokubo; Toru Hyodo
Journal:  J Artif Organs       Date:  2022-02-28       Impact factor: 1.731

4.  Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity.

Authors:  Francis Mussai; Sharon Egan; Stuart Hunter; Hannah Webber; Jonathan Fisher; Rachel Wheat; Carmel McConville; Yordan Sbirkov; Kate Wheeler; Gavin Bendle; Kevin Petrie; John Anderson; Louis Chesler; Carmela De Santo
Journal:  Cancer Res       Date:  2015-06-08       Impact factor: 12.701

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.